Your session is about to expire
← Back to Search
Progressive Feeding without MEF for Premature Birth
N/A
Waitlist Available
Led By Ariel A. Salas, MD, MSPH
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
admission to the NICU within 48 hours with gestational age between 22.0 and 28.6 weeks
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up birth to 120 days
Awards & highlights
Study Summary
This trial will compare two different feeding schedules for extremely premature infants. One group will receive progressive feeding without MEF, while the other group will receive MEF for four days before progressive feeding. The goal is to see if the group that received MEF will have more infants alive and on full enteral feeding after 28 days.
Eligible Conditions
- Premature Birth
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ birth to 120 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~birth to 120 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of days alive and receiving full enteral feeding
Secondary outcome measures
Fecal Microbiota Transplantation
Death
Duration of hospital stay in days
+10 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Progressive Feeding without MEFExperimental Treatment1 Intervention
This group will receive feeding volumes of 20-24ml/kg/d of day 1 of feeding followed by the study intervention of daily volume increases in increments of 24-25ml/kg/d as tolerated until full enteral feeding is achieved.
Group II: Progressive Feeding with MEFActive Control1 Intervention
This group will receive minimal enteral feeds (MEF) with volumes of 20-24ml/kg/d for 4 days followed by daily increases in increments of 24-25ml/kg/d as tolerated until full enteral feeding is achieved.
Find a Location
Who is running the clinical trial?
University of Alabama at BirminghamLead Sponsor
1,581 Previous Clinical Trials
2,277,969 Total Patients Enrolled
22 Trials studying Premature Birth
28,238 Patients Enrolled for Premature Birth
The Gerber FoundationOTHER
41 Previous Clinical Trials
5,936 Total Patients Enrolled
6 Trials studying Premature Birth
795 Patients Enrolled for Premature Birth
Ariel A. Salas, MD, MSPHPrincipal InvestigatorUniversity of Alabama at Birmingham
4 Previous Clinical Trials
186 Total Patients Enrolled
2 Trials studying Premature Birth
80 Patients Enrolled for Premature Birth
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger